Just out the results of our #metanalysis on the use of hormone replacement therapy in #breastcancer survivors. ‼️HR 1.46 for risk of disease recurrence 👉🏻subgroup analyses for subtypes of disease and type of HRT Marco Tagliamento Matteo Lambertini, MD PhD OncoAlert #bcsm link.springer.com/article/10.100…

#Immunotherapy with immune checkpoint inhibitors is associated with better quality of life than chemotherapy in our meta-analysis of 17 RCTs out now on European Journal of Cancer Thanks to my co-authors Andrea Boutros Enrica Tanda Luca Arecco, MD Matteo Lambertini, MD PhD ejcancer.com/article/S0959-…

#Immunoterapia vs #Chemioterapia: la prima garantisce una qualità di vita migliore perché stabilizza il #tumore, anche quando non lo riduce. La metanalisi di Andrea Boutros e Francesco Spagnolo pubblicata su European Journal of Cancer. OncoAlert Leggi di più: ospedalesanmartino.it/ricerca-scient…

Grazie a Ospedale San Martino Genova e GRAZIE a tutto il super gruppo dei coautori❗️ Francesco Spagnolo Enrica Tanda Luca Arecco, MD Matteo Lambertini, MD PhD Università di Genova

Proud to share this other OnCovid effort about the time-dependent improvement of COVID outcomes in pts with cancer Surgery and Cancer David James Pinato 🇺🇦 Alessandra Gennari MD PhD UPO - Università Aleix Prat #PrecisionOncology Josep Tabernero Matteo Lambertini, MD PhD Tom Newsom-Davis jamanetwork.com/journals/jamao…

Proud to present our Università di Genova Ospedale San Martino Genova contribution for this super #SABCS21! ➡️ 3 Spotlight presentations ➡️ 9 Posters Looking forward for my 1st poster discussion with my prof Matteo Lambertini, MD PhD on #fertilitypreservation and life #after BC 🗓 Dec 8th - 5:00 PM CT OncoAlert

La #chemio minaccia le ovaie, un farmaco le protegge. Il trattamento è efficace e sicuro per le giovani donne colpite da #tumorealseno Studio di Matteo Lambertini, MD PhD e Lucia Del Mastro, supportato da fondi #5x1000 del @SanMartino_GE e da Fondazione AIRC per la ricerca sul cancro JNCI ospedalesanmartino.it/ricerca-scient…

The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma IMI - Intergruppo Melanoma Italiano provide a literature review and clinical recommendations mdpi.com/1446998 #mdpicancers Cancers MDPI #skincancer IRST "Dino Amadori" IRCCS Francesco Spagnolo Paolo A. Ascierto Pietro Quaglino Iris Zalaudek @mandalamario

Honored to receive the #BFSA2022 award and to present the results of our meta-analysis to such a great audience. Thanks to my professors and mentors Lucia Del Mastro and Matteo Lambertini, MD PhD 🙏🏼 Special thanks to Eva Blondeaux and all the co-authors for the support!

Proud to share again this 2020' 🇮🇹 collaboration recently awarded by Journal for ImmunoTherapy of Cancer Paolo A. Ascierto David James Pinato 🇺🇦 Alessandro Russo Francesco Spagnolo Raffaele Giusti Marco Filetti

So proud to share the latest work led by my friend Luca Arecco, MD fellow at Università di Genova Ospedale San Martino Genova online in ESHRE OUP Medicine journal #HumReprod: #fertility preservation is safe in young #BreastCancer patients OncoAlert #UNIGEnonsiferma #SurvOnc #bcsm academic.oup.com/humrep/advance…

1/5 Thrilled to share our metanalysis finally published on ESHRE OUP Medicine journal #HumReprod aiming to assess the #safety of fertility preservation techniques before and after anticancer treatments in young women with #breastcancer 📃Link: academic.oup.com/humrep/advance…

Approval of this new combination #immunotherapy for advanced melanoma patients will improve outcomes & likely impact cancer treatment globally. The next step is TGA Australia approval & consideration by the Pharmaceutical Benefits Advisory Committee (#PBAC) to be funded in Australia.

What a great news to celebrate your birthday Luca Arecco, MD !!! Congrats, very important data to improve the #oncofertility counseling of our young women with #BreastCancer OncoAlert Università di Genova #UNIGEnonsiferma #ospedalesanmartino #ResearchSavesLives #mentorshipIsKey #bcsm #SurvOnc

Our OncoAlert king giving a fantastic overview on #SoMe use in #oncology at the #YoungToYoung conference in beautiful #Meridiana palace in #Genova…so proud and excited to have you visiting us!!! ESMO - Eur. Oncology ESOncology Accademia Medicina Francesco Spagnolo Carlo Genova Università di Genova Ospedale San Martino Genova

Ciao #Liguria! Also known as the Italian Riviera, this region has a beautiful coastline featuring many picturesque port cities. Genoa and La Spezia are just two of them! #CiaoItaly #MissionMinerva European Space Agency ESA_Italia Human Spaceflight ESA Earth Observation International Space Station

1/3 Just published in The Lancet Oncology the 15-y follow-up data of #GIM2 trial: ✅ Impressive benefit both in #DFS (+8.5%) and #OS (+7%) rates of dose-dense adjuvant CT in high risk breast cancer patients.

Great presentation by our colleague and friend Andrea Boutros on 2nd day of this Young AIOM 2023 on melanoma. 🔎 focus on: 1. mRNA vaccine + Pembro promising adjuvant therapy 2. IPI+NIVO 1st standard line even in BRAFm 3. Tebentafusp standard tp for uveal metastatic melanoma

The Università di Genova Ospedale San Martino Genova crew at #ESMO23 🇮🇹❤️🤩💪🔝 Lucia Del Mastro ESMO - Eur. Oncology OncoAlert Marco Tagliamento Francesco Spagnolo Carlo Genova Diletta Favero Eva Blondeaux Roberto Borea Davide Soldato Benedetta Conte

💫 What an honour to see our work on Early discontinuation of ICI in #elderly with #cscc cited by Teresa Amaral, MD, PhD during ESMO - Eur. Oncology session on survivorship in the era of #immunotherapy 🫶🏽 Università di Genova Ospedale San Martino Genova Francesco Spagnolo Matteo Lambertini, MD PhD Enrica Tanda Luca Arecco, MD